v3.22.2.2
Balance Sheet Details (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Balance Sheet Details [Abstract]    
Schedule of prepaid expenses
   September 30,
2022		   December 31,
2021		 
Prepaid clinical costs  $
—
   $488,614 
Prepaid insurance   206,270    
—
 
Other prepaid expenses & current assets   103,358    148,728 
Total prepaid expenses & current assets  $309,628   $637,342 

 
   December 31,
2021		   December 31,
2020		 
Prepaid clinical costs  $488,614   $
—
 
Other prepaid expenses   148,728    128,000 
Total prepaid expenses  $637,342   $128,000 

 
Schedule of property and equipment, net
   September 30,
2022		   December 31,
2021		 
Lab equipment  $131,962   $131,963 
Total property and equipment, gross   131,962    131,963 
Accumulated depreciation   (35,567)   (16,782)
Total property and equipment, net  $96,395   $115,181 

 
   December 31,
2021		 
Lab Equipment  $131,963 
Total property and equipment, gross   131,963 
Accumulated depreciation   (16,782)
Total property and equipment, net  $115,181 

 
Schedule of current liabilities
   September 30,
2022		   December 31,
2021		 
Accrued payroll and related expenses  $678,452   $756,729 
Accrued clinical study expenses   109,483    327,244 
Accrued professional fees   40,614    294,130 
Accrued clinical development costs   90,000    145,566 
Accrued other expenses   4,565    5,000 
Premium Finance Agreement - D&O Insurance   73,333    
—
 
Total accrued expenses  $996,447   $1,528,669 

 
   December 31,
2021		   December 31,
2020		 
Accounts payable  $596,261   $865,901 
Accrued payroll and related expenses   756,729    266,852 
Accrued clinical study expenses   327,244    40,329 
Accrued professional fees   294,130    23,216 
Accrued clinical development costs   145,566    
—
 
Accrued other expenses   5,000    12,478 
Lease liability   16,752    
—
 
Total current liabilities  $2,141,682   $1,208,776